Great Diamond Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
535
+108
| +25% | +$56.7K | 0.06% | 193 |
|
|
2025
Q1 | $271K | Buy |
427
+98
| +30% | +$62.2K | 0.07% | 149 |
|
|
2024
Q4 | $234K | Sell |
329
-6
| -2% | -$4.27K | 0.06% | 161 |
|
|
2024
Q3 | $352K | Sell |
335
-254
| -43% | -$267K | 0.09% | 135 |
|
|
2024
Q2 | $619K | Sell |
589
-10
| -2% | -$10.5K | 0.15% | 117 |
|
|
2024
Q1 | $577K | Sell |
599
-8
| -1% | -$7.7K | 0.13% | 123 |
|
|
2023
Q4 | $533K | Sell |
607
-17
| -3% | -$14.9K | 0.13% | 127 |
|
|
2023
Q3 | $514K | Buy |
624
+1
| +0.2% | +$823 | 0.14% | 128 |
|
|
2023
Q2 | $448K | Buy |
623
+26
| +4% | +$18.7K | 0.12% | 137 |
|
|
2023
Q1 | $491K | Buy |
597
+4
| +0.7% | +$3.29K | 0.14% | 127 |
|
|
2022
Q4 | $428K | Sell |
593
-129
| -18% | -$93.1K | 0.13% | 134 |
|
|
2022
Q3 | $497K | Buy |
722
+1
| +0.1% | +$688 | 0.17% | 121 |
|
|
2022
Q2 | $426K | Sell |
721
-196
| -21% | -$116K | 0.14% | 126 |
|
|
2022
Q1 | $640K | Sell |
917
-53
| -5% | -$37K | 0.18% | 106 |
|
|
2021
Q4 | $612K | Buy |
970
+1
| +0.1% | +$631 | 0.16% | 115 |
|
|
2021
Q3 | $586K | Sell |
969
-2
| -0.2% | -$1.21K | 0.16% | 109 |
|
|
2021
Q2 | $542K | Hold |
971
| – | – | 0.15% | 115 |
|
|
2021
Q1 | $459K | Sell |
971
-46
| -5% | -$21.7K | 0.14% | 122 |
|
|
2020
Q4 | $491K | Sell |
1,017
-67
| -6% | -$32.3K | 0.16% | 107 |
|
|
2020
Q3 | $606K | Buy |
1,084
+6
| +0.6% | +$3.35K | 0.22% | 79 |
|
|
2020
Q2 | $672K | Sell |
1,078
-54
| -5% | -$33.7K | 0.28% | 68 |
|
|
2020
Q1 | $552K | Sell |
1,132
-37
| -3% | -$18K | 0.28% | 68 |
|
|
2019
Q4 | $438K | Buy |
+1,169
| New | +$438K | 0.17% | 86 |
|